RALEIGH, N.C., April 17 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it will present at the Third Annual World Drug Safety Congress scheduled for April 21-24, 2009, in Washington, D.C. Dr. Sabine Richter, Vice President of Safety and Risk Management at PRA, will chair the session, while Mark Nelson Tyrrell, Director of Risk Management at PRA, will discuss “Assessment of stakeholders for risk mitigation strategies.” The discussion will focus on the design, implementation, and ongoing evaluation of Phase-IV studies, registries and observational studies, and RiskMAP / REMS development.
From pre-clinical proof of concept, to end of phase, to post-approval - PRA specializes in designing all components of risk management planning. Areas of specialty include:
PRA offers its clients a dedicated team of physicians, nurses, pharmacists, biostatisticians, pharmacoepidemiologists and medical writers - each qualified through years of experience in risk management activities. Members of the team have contributed to many of the FDA-REMS programs currently in effect, focusing on dermatology, oncology and immune disorders. PRA has implemented programs in support of novel drugs and biologicals, such as TNFa blockers, as well as mature products such as antiepileptic drugs.
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA’s therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.
CONTACT: Roger Boutin, Director of Marketing of PRA International, Inc.,
+1-434-951-3924
Web site: http://www.prainternational.com/
